Chronic hepatitis C and interferon alfa therapy: Predictors of long term response

Medical Journal of Australia

Volumn 164, Issue 3, 1996, Pages 150-152

  Jenkins, Peter J ^a   Cromie, Suzanne L ^a   Bowden, D Scott ^b   Finch, Caroline F ^a   Dudley, Francis J ^a  

^a ALFRED HOSPITAL   (Australia)

^b FAIRFIELD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; GAMMA GLUTAMYLTRANSFERASE; VIRUS RNA;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; FATTY LIVER; FEMALE; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; STATISTICAL ANALYSIS; VIRUS TITRATION;

EID: 0030061694     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb122013.x     Document Type: Article

References (23)

1. Davis GL, Balart LA, Schiff ER. et al. Treatment of chronic hepatitis with recombinant Interferon alfa a multicentre randomized controlled trial N Engl J Med 1989, 321. 1501-1506.
2. Tine F, Magrin S, Craxi A, Pagliaro L. Interferon for non-A, non-B chronic hepatitis a meta-analysis of randomised clinical trials J Hepatol 1991, 13: 192-199
3. Shindo M, Di Bisceglie AM. Cheung L, et al Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C Ann Intern Med 1991; 115. 700-704
4. Castillo I, Bartolome J, Navas S, et al Virological and biochemical long-term follow-up of patients with chornic hepatitis C treated with Interferon Hepatology 1994, 19 1342-1346
5. Lau JYN, MizoKami M, Ohno T. et al. Discrepancy between virologic and biochemical response in interferon-alpha (IFN) therapy in chronic hepatitis C virus (HCV) infection Lancet 1993; 342 1208-1209
6. Fried MW, Hoofnagle JH Therapy of hepatitis C. Semin Liver Dis 1995, 15 82-91
7. Chayama K, Koida J, Tsubota A, et al. The change of serial amino acid sequence in the hypervariable region of hepatitis C virus during repeated Interferon treatment Comparison of changes in patients during long term following up Hepatology 1993; 18. 226A
8. Davis GL Prediction of response to interferon treatment of chronic hepatitis C J Hepatol 1994 21 1-3
9. Tsubota A. Chayama K, Ikeda K, et al. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection Hepatology 1994; 19 1088-1094
10. Yoshioka K, Kakumu S, Wakita T, et al Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy. relationship to genotypes of hepatitis C virus Hepatology 1992, 16 293-299
11. Hino K, Sainokamo S, Shomida K. et al Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C J Med Virol 1994, 42: 299-305
12. Kobayashi Y, Watanabe S, Konishi M. et al Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferonbeta. Hepatology 1993; 1319-1325
13. Dusheiko G. Schmilovitz-Weiss H, Brown D, et al Hepatitis C virus genotypes an investigation of typespecific differences in geographic origin and disease Hepatology 1994, 19 13-18
14. Lau JYN, Davis GL, Kniffen J, et al Significance of serum hepatitis C virus RNA levels in chronic hepatitis C Lancet 1993, 341 1501-1504
15. Gretch DR, dela Rosa C, Carithers Jr RL, et al Assessment of hepatitis C viraemia using molecular amplification technologies Correlations and clinical implications Ann Intern Med 1995, 123 321-329.
16. Swanson NR, Larev RR, Tuffin MJ, et al Australian hepatitis C virus (HCV) genotypes J Gastrenterol Hepatol 1994; 9 A92
17. Scheuer PJ. Classification of chronic viral hepatitis a need for reassessment. J Hepatol 1991, 13. 372-374
18. Stuyver L, Rossau R, Wyseur A, et al Typing of hepatitis C virus isolates and characterisation of new (sub)types using a line probe assay. J Gen Virol 1991; 74: 1093-1102
19. Samuel CE Antiviral actions of interferon Interferon-regulated cellular proteins and their surprisingly selective antiviral activities Virology 1991, 183 1-11.
20. Nousbaum JB, Pol S, Nalpas B, et al. Hepatitis C virus type 1 b(II) infection in France and Italy. Ann Intern Med 1995; 122 161-168
21. Marcellin P, Pouteau M, Martinot-Peignoux M, et al Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C Gastroenterology 1995, 109 156-165
22. Brillanti S, Garson J, Foli M, et al A pilot study of combination therapy with ribavirin plus interferon-alfa for interferon-alfa resistant chronic hepatitis C. Gastroenterology 1994; 107. 812-817
23. Oshita M, Hayashi N, Kasahara A, et al Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C Hepatology 1994; 20. 1115-1120